- 関
- camostat
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
- Yamaya M1, Shimotai Y2, Hatachi Y3, Lusamba Kalonji N4, Tando Y5, Kitajima Y6, Matsuo K7, Kubo H4, Nagatomi R6, Hongo S2, Homma M8, Nishimura H8.
- Pulmonary pharmacology & therapeutics.Pulm Pharmacol Ther.2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10.
- BACKGROUND: Serine proteases act through the proteolytic cleavage of the hemagglutinin (HA) of influenza viruses for the entry of influenza virus into cells, resulting in infection. However, the inhibitory effects of serine protease inhibitors on influenza virus infection of human airway epithelial
- PMID 26166259
- Protease inhibitors targeting coronavirus and filovirus entry.
- Zhou Y1, Vedantham P2, Lu K3, Agudelo J3, Carrion R Jr4, Nunneley JW4, Barnard D5, Pöhlmann S6, McKerrow JH7, Renslo AR2, Simmons G8.
- Antiviral research.Antiviral Res.2015 Apr;116:76-84. doi: 10.1016/j.antiviral.2015.01.011. Epub 2015 Feb 7.
- In order to gain entry into cells, diverse viruses, including Ebola virus, SARS-coronavirus and the emerging MERS-coronavirus, depend on activation of their envelope glycoproteins by host cell proteases. The respective enzymes are thus excellent targets for antiviral intervention. In cell culture, a
- PMID 25666761
- The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.
- Ueda M1, Uchimura K, Narita Y, Miyasato Y, Mizumoto T, Morinaga J, Hayata M, Kakizoe Y, Adachi M, Miyoshi T, Shiraishi N, Kadowaki D, Sakai Y, Mukoyama M, Kitamura K.
- Nephron.Nephron.2015;129(3):223-32. doi: 10.1159/000375308. Epub 2015 Mar 3.
- BACKGROUND/AIMS: We have so far demonstrated the renoprotective effect of camostat mesilate (CM) in 5/6 nephrectomized rats at least partly through its antioxidant effect. However, precise mechanisms were not fully clarified. Therefore, we now examined the renoprotective and antioxidant mechanisms o
- PMID 25766432
Japanese Journal
- Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease
- SAI Jin Kan,SUYAMA Masafumi,KUBOKAWA Yoshihiro,MATSUMURA Yuji,INAMI Koichi,WATANABE Sumio
- Journal of gastroenterology 45(3), 335-341, 2010-03-01
- NAID 10027215227
- メシル酸カモスタット増量により高アミラーゼ血症の改善が得られた潰瘍性大腸炎合併慢性膵炎の1例
- 福田 重信,宮谷 博幸,本田 英明,高松 徹,福西 昌徳,岩城 孝明,宇賀神 卓広,中島 嘉之,鷺原 規喜,吉田 行雄
- 膵臓 = The Journal of Japan Pancreas Society 23(4), 533-540, 2008-08-25
- NAID 10024367913
- PE-162 Poly(lactic-co-glycolic acid) Nanospheres Containing Protease Inhibitors, Camostat Mesilate and Nafamostat Mesilate : Therapeutic Potential for Treating Atherosclerosis(Cardiovascular pharmacology, basic/clinical(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Fujii Satoshi,Noda Yasuhiro,Hazemoto Norio
- Circulation journal : official journal of the Japanese Circulation Society 72(Supplement_I), 400-401, 2008-03-01
- NAID 110006798051
Related Links
- Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and ... Description Camostat is a trypsin-like protease inhibitor, inhibits airway ...
- Sigma-Aldrich offers Sigma-SML0057, Camostat mesylate for your research needs. Find product specific information including CAS, MSDS, protocols and references. ... Application Camostat mesylate may be used in cell signaling ...
★リンクテーブル★
[★]
- 英
- camostat
- 化
- メシル酸カモスタット camostat mesilate カモスタットメシル酸塩
- 商
- アーチメント、カモエント、カモスタール、カモステート、カモストン、カモタット、カルモザシン、パンクレール、パンルーク、フオイパン、メシタット、メシルパン、モスパン、ラインタット、リーナック、リビリスター、レセプロン
- 関
- 他に分類されない代謝性医薬品
作用機序
- フオイパン錠100mg
- 本剤は経口投与ですみやかに生体のキニン生成系、線溶系、凝固系及び補体系に作用し、その酵素活性をすみやかに阻害し異常亢進を抑制することにより、慢性膵炎の炎症症状と疼痛の緩解並びにアミラーゼ値の改善に効果が認められている。また、術後食道内に逆流する消化液中のトリプシンを阻害することにより、術後逆流性食道炎の改善に効果が認められている。
効能又は効果/用法及び用量
- フオイパン錠100mg
- 1. 慢性膵炎における急性症状の緩解
- 2. 術後逆流性食道炎
添付文書
- http://www.info.pmda.go.jp/go/pack/3999003F1297_1_05/3999003F1297_1_05?view=body
[★]
メシル酸、(化合物)シル酸塩、メタンスルホン酸塩
- 関
- mesylate、methanesulfonate